Who We Are at World Stem Cells, LLC
Advanced stem cell treatments offered by Would Stem Cells, LLC for qualified patients at our medical facilities World Stem Cells Clinic, http://worldstemcells.com/clinic-team.html in Cancun provides an opportunity for a better quality of life. The clinic and laboratory were designed, built and are operated under the stringent guidelines as established by The International Cellular Medical Society (ICMS) and the US Federal Drug Administrations Good Tissue Practice (cGTP)regulations for pharmaceutical, biologics and clinical laboratories. The strict adherence to these established guidelines and policies guarantees the highest quality of clinical care and stem cell treatment safety for you.
What Is Done
World Stem Cells Clinics medical staff and clinical physicians will examine you and review all available medical records, radiology films, CT scans and other diagnostic information to assess if stem cell therapy will be a helpful primary treatment or adjunctive therapy for your specific condition.
Then, the medical doctors meet and confer with the research scientists for a pre-treatment planning meeting. This Stem cell treatment planning conference takes advantage of decades of the staffs clinical experience, your current condition, your available social support system, full review of your medical history as well as an inclusion and consideration of any recently published research literature on stem cell treatments. In other words, you are provided a detailed, systematic and entirely unique treatment care plan for his or her needs.
Sorry, they do not perform a one or two day treatment as it would not be medically sound and could not provide the benefits or safety that the World Stem Cells Clinic treatment schedule gives (please do not be fooled). Your Stem Cell Treatment at World Stem Cells Clinic takes 5 days to complete as the treatments are comprehensive and designed to maximize the benefits and safety you derive from the process.
How Is It Done
The World Stem Cells Clinics team harvest autologous stem cells from your own bone marrow, adipose (fat) tissue or circulating stem cells, within your bloodstream. They also offer allogeneic stem cells from other donors. These cells are harvested in the same way and under the same conditions. They are simply obtained from a donor as opposed to from you. They do not utilize fetal or laboratory-cultured embryonic stem cells. They chose not to use these sources of stem cells to prevent potential complications from contamination or side effects and adverse events such as graft versus host disease (GVHD).
After collection, your stem cells are tested and processed at the state-of-the-art and Good Tissue Practice (cGTP) laboratories. Data regarding the source of your stem cells, the amount harvested, and other information is recorded to ensure proper transfusion of your own cell or those of a chosen donor.
Following stem cell treatment, World Stem Cells, LLC in conjunction with the The International Cellular Medical Society (ICMS), remains in contact with you and your families to assess the treatment results. Treatment protocols and treatment outcomes without any identifying personal information will be openly accessible to all stem cell researchers in the field to promote new technologies, safer stem cell treatment protocols, promote overall patient safety and aid in the advancement of stem cell transplant science.
View post:
World Stem Cells,LLC | Stem Cell Treatments & Stem Cell Therapy
- USC biological imaging innovator elected to National Academy of Medicine > News > USC Dornsife - USC Dornsife College of Letters, Arts and... - October 24th, 2020
- Repurposing and Combining Drugs An Effective Cancer Treatment Strategy - Technology Networks - October 24th, 2020
- Rates of Invasive Pulmonary Aspergillosis in ICU Patients With Influenza Far Lower Than Previously Thought - Contagionlive.com - October 24th, 2020
- Stem Cell and Regenerative Therapy Market Report to Describe Major Companies and Their Strategies (2019-2024) - PRnews Leader - October 23rd, 2020
- Baby Gets Early Stem Cell Transplant to Treat Rare Disease Thanks to Newborn Screening - University of Michigan Health System News - October 23rd, 2020
- Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn - GlobeNewswire - October 23rd, 2020
- Orchard Therapeutics CEO Bobby Gaspar, M.D., Ph.D., Appointed to the Alliance for Regenerative Medicine's 2021 Board of Directors - GlobeNewswire - October 23rd, 2020
- Be Biopharma debuts with $52M to advance engineered B-cell therapies - FierceBiotech - October 23rd, 2020
- Five Penn faculty elected to the National Academy of Medicine - Penn Today - October 21st, 2020
- Vor Biopharma Appoints Matthew R. Patterson to its Board of Directors - BioSpace - October 21st, 2020
- Harvard Business School and Harvard's Department of Stem Cell and Regenerative Biology Receive $25 Million Gift from Chris and Carrie Shumway to... - October 20th, 2020
- Human Embryonic Stem Cells (HESC) Industry Research Report, Growth Trends and Competitive Analysis 2020-2027: ESI BIO, Thermo Fisher, BioTime,... - October 20th, 2020
- Notch Therapeutics Strengthens Leadership Team with Appointment of Kamran Alam as CFO and Gregory Block as SVP, Corporate Development - PRNewswire - October 20th, 2020
- Global Induced Pluripotent Stem Cells (iPSCs) Market 2020 Potential Growth, Competitive Landscape and Development of Industry by 2025 Wall Street... - October 20th, 2020
- Regenerative Medicine Market 2020 Industry Insights by Share, Emerging Trends, Regional Analysis, Segments, Prime Players, Drivers, Growth Factor and... - October 20th, 2020
- The untapped market of cord blood banking - The Malaysian Reserve - October 15th, 2020
- Singapore invents digitized optimization of culture conditions for cell therapy - BSA bureau - October 15th, 2020
- Pluristem Announces Clearance to Move Forward with Enrollment for Cohort II in an Investigator-Led Phase I/II Chronic Graft vs Host Disease... - October 15th, 2020
- U of T's Medicine by Design invests $1 million to advance new ideas in regenerative medicine - News@UofT - October 10th, 2020
- Proposition 14 would authorize state to borrow $5.5 billon for stem cell research - KESQ - October 10th, 2020
- AIVITA Biomedical's Stem Cell Therapeutic in Vision Loss Published in Investigative Ophthalmology & Vision Science - PRNewswire - October 10th, 2020
- Regenerative Medicine Market | Increasing Prevalence of Chronic Diseases to Boost the Market Growth | Technavio - Business Wire - October 10th, 2020
- University of Wisconsin Researchers Use Stem Cells to Treat Parkinson's - Gilmore Health News - October 10th, 2020
- Cartilage Repair/ Cartilage Regeneration Market worth $1,603 million by 2025 - Exclusive Report by MarketsandMarkets - PRNewswire - October 10th, 2020
- Mission: a cure to cancer - Innovation Origins - October 10th, 2020
- What You Need to Know About Prop 14, The Stem Cell Research Bond (Transcript) - KQED - October 3rd, 2020
- SMART researchers receive Intra-CREATE grant for personalized medicine and cell therapy - MIT News - October 3rd, 2020
- Abu Dhabi Stem Cells Centre collaborating with Israeli firm for COVID-19 therapies - Gulf News - October 3rd, 2020
- Majority of Respondents Support Chimeric Animal Research: Survey - The Scientist - October 3rd, 2020
- Hair Regeneration Therapy Company Stemson Therapeutics Raises $7.5 Million - Pulse 2.0 - September 21st, 2020
- Election 2020: Prop. 14 and stem cell research funding - KCBX - September 21st, 2020
- Intestinal Organoid Built That Looks and Functions Like Real Tissue - Genetic Engineering & Biotechnology News - September 21st, 2020
- Recruiting Faculty in Molecular and Cellular Biology - Nature.com - September 19th, 2020
- Regenerative Therapy by Dr. Roshni Patel on Better CT - Farmington, CT - Patch.com - September 19th, 2020
- California's $7.8 Billion Proposition 14 Could Expand Conflicts of Interest in Stem Cell Research | K. Lloyd Billingsley - The Beacon - September 15th, 2020
- GA sues therapists after making $6.4 Million on unproven products - ValdostaToday.com - September 15th, 2020
- NK Cell Therapy and Stem Cell Therapy Market Report 2020 (COVID-19 Impact Analysis) By Segmentations, Key Company Profiles & Demand Forecasts to... - September 15th, 2020
- LifeGaines Medical and Aesthetics Center in Boca Raton Helps Patients Stay Young and Healthy - Yahoo Finance - September 15th, 2020
- New research connects the hormones we're born with to lifetime risk for immunological diseases - MSUToday - September 15th, 2020
- The Tax Watchers: How would you spend other people's money? - Fairfield Daily Republic - September 11th, 2020
- Global Stem Cell Reconstructive Market- Industry Analysis and Forecast (2020-2027) - Kewaskum Statesman News Journal - September 11th, 2020
- Plinabulin Granted FDA Breakthrough Therapy Designation for Chemotherapy-Induced Neutropenia - Targeted Oncology - September 11th, 2020
- GSK and J&J; alum Vijay Reddy to take control of R&D; at Tmunity; Andrew Hirsch exits Agios for CEO job at C4 Therapeutics - Endpoints News - September 11th, 2020
- New Data Further Reinforce Genentech's Ocrevus (ocrelizumab) as a Highly Effective Treatment for People With Multiple Sclerosis - BioSpace - September 11th, 2020
- Stem Cells Market Report, History and Forecast 2020-2027, Data Breakdown by Manufacturers, Key Regions, Types and Application - News Degree - September 11th, 2020
- Global Organoids and Spheroids Market Is Expected to Reach USD 2794.79 Million by 2027 : Fior Markets - GlobeNewswire - September 8th, 2020
- School of Science grows by 10 - MIT News - September 8th, 2020
- Faculty of Medicine researchers receive $2.8m for equipment and infrastructure - UBC Faculty of Medicine - UBC Faculty of Medicine - September 8th, 2020
- BeyondSpring Receives Breakthrough Therapy Designations from Both U.S. FDA and China NMPA for Plinabulin in Chemotherapy-Induced Neutropenia... - September 8th, 2020
- New HIV Gene Therapy, CAR-T Treatments Could be on the Horizon for Patients - BioSpace - September 4th, 2020
- Insights on the Global Animal Medicine Market to 2030 - Featuring Zoetis, Boehringer Ingelheim & Bayer Among Others - ResearchAndMarkets.com -... - September 4th, 2020
- Stem Cell And Regenerative Therapy Market Insights And Forecast 2019-2024 - Scientect - September 4th, 2020
- Magenta Therapeutics Appoints Lisa M. Olson as Chief Scientific Officer and Kevin B. Johnson as Senior Vice President, Head of Regulatory and Quality;... - September 4th, 2020
- Unraveling the use of CBD in veterinary medicine - Jill Lopez - September 4th, 2020
- BioForward Recognizes Scientific and Business Success with Annual Wisconsin Biohealth Awards - Business Wire - September 4th, 2020
- Biopreservation Market share forecast to witness considerable growth from 2020 to 2025 | By Top Leading Vendors , STEMCELL Technologies, WAK-Chemie... - September 4th, 2020
- An ancient virus might have made our hearts bigger - Scope - Scope - September 4th, 2020
- Worldwide Human Microbiome Immunology Therapeutics Industry to 2025 - The US Dominates the Global Market Landscape - PRNewswire - September 4th, 2020
- IFITM3 Forges Link Between Neuroinflammation and A Production - Alzforum - September 4th, 2020
- 3D Cell Culture Market 2020 by Application (Cancer Research, Stem Cell Research, Drug Discovery, Regererative Medicine), Top Countries Data with... - August 17th, 2020
- Researcher John Craig Venter Is Awarded the 2020 Edogawa-NICHE Prize for His Accomplishment in Human Genome Research - Financialbuzz.com - August 17th, 2020
- Every Sumatran rhino has died in Malaysia. Scientists want to bring them back with cloning technology - CNN - August 15th, 2020
- Brain Tumor Therapeutics Market 2020 Overview by Market Size, Share, Growth Rate, Products and Recent Developments, Forecast till 2023 - The Daily... - August 15th, 2020
- Cellect Biotechnology Ltd ADR (NASDAQ:APOP) Receives an Approval of a Pivotal Patent for Stem Cells Activation from the European Patent Office - BP... - August 15th, 2020
- Crispr Therapeutics: My #1 High-Risk Investment Idea - Seeking Alpha - August 15th, 2020
- Cell Expansion Market Research Report by Product, by Cell Type, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19... - August 13th, 2020
- NYC Healthcare Heroes Successfully Delivers More Than 400000 Care Packages with More Than 15 Million Products to 100 Hospitals and Healthcare... - August 13th, 2020
- Kerala Crash: A pregnant woman missed the flight because she didn't have a fit-to-fly certificate. But what is it and why do you need one? - Gulf News - August 13th, 2020
- Science News Roundup: Stem cells give hope for revival of Malaysia's extinct rhinos; Human versus disease showcased and more - Devdiscourse - August 13th, 2020
- Cellect Biotechnology Reports Second Quarter Financial and Operating Results; First Half 2020 Strategic Developments Create Long-Term Revenue... - August 12th, 2020
- California Propositions on the 2020 Ballot - Fullerton Observer - August 12th, 2020
- Gore partners with San Diego company on cell delivery system with potential to treat Type 1 diabetes - delawarebusinessnow.com - August 12th, 2020
- FibroGenesis Reports Breakthrough in Prevention of COVID-19 Blood Clotting Laboratory Studies Suggest PneumoBlast COVID-19 Cell Therapy Reduces... - August 12th, 2020
- The Proteus Effect: Stem Cells and Their Promise for Medicine - August 10th, 2020
- Marker Therapeutics Reports Second Quarter 2020 Operating and Financial Results - PRNewswire - August 10th, 2020
- New Report: Regenerative Medicine & Advanced Therapies Sector Thriving Despite COVID-19 - PharmiWeb.com - August 10th, 2020
- Regenerative Medicine & Stem Cell Practice in Medical Spas ... - August 10th, 2020
- Global Stem Cell Therapy Market Research Analysis Including Growth Factors, Types And Application By Regions From 2020 To 2024 - Owned - August 9th, 2020
- Dad with incurable cancer takes on 300 mile cycle challenge ahead of stem cell transplant - HeraldScotland - August 9th, 2020
- Potential Impact of COVID-19 Pandemic on Global Stem Cell Assay Coronavirus Impact Editon of Key Companies Merck, Thermo Fisher Scientific, GE... - August 8th, 2020
